162 related articles for article (PubMed ID: 24178245)
1. Expression of STAT3 and IGF2 in adrenocortical carcinoma and its relationship with angiogenesis.
Zhu Y; Xu Y; Chen D; Zhang C; Rui W; Zhao J; Zhu Q; Wu Y; Shen Z; Wang W; Ning G; Wang X
Clin Transl Oncol; 2014 Jul; 16(7):644-9. PubMed ID: 24178245
[TBL] [Abstract][Full Text] [Related]
2. Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy.
Xu YZ; Zhu Y; Shen ZJ; Sheng JY; He HC; Ma G; Qi YC; Zhao JP; Wu YX; Rui WB; Wei Q; Zhou WL; Xie X; Ning G
Endocrine; 2011 Dec; 40(3):445-51. PubMed ID: 21706269
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and Lymphangiogenesis in the Adrenocortical Tumors.
Pereira SS; Costa MM; Guerreiro SG; Monteiro MP; Pignatelli D
Pathol Oncol Res; 2018 Jul; 24(3):689-693. PubMed ID: 28695321
[TBL] [Abstract][Full Text] [Related]
4. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
5. Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms.
Erickson LA; Jin L; Sebo TJ; Lohse C; Pankratz VS; Kendrick ML; van Heerden JA; Thompson GB; Grant CS; Lloyd RV
Endocr Pathol; 2001; 12(4):429-35. PubMed ID: 11949624
[TBL] [Abstract][Full Text] [Related]
6. Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations.
de Fraipont F; El Atifi M; Gicquel C; Bertagna X; Chambaz EM; Feige JJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4734-41. PubMed ID: 11134136
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.
Diaz-Cano SJ; de Miguel M; Blanes A; Galera H; Wolfe HJ
Hum Pathol; 2001 Nov; 32(11):1232-9. PubMed ID: 11727263
[TBL] [Abstract][Full Text] [Related]
10. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?
Bulzico D; Faria PAS; Maia CB; de Paula MP; Torres DC; Ferreira GM; Pires BRB; Hassan R; Abdelhay E; Vaisman M; Vieira Neto L
Endocrine; 2017 Nov; 58(2):276-288. PubMed ID: 28887601
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
Wang C; Sun Y; Wu H; Zhao D; Chen J
Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
[TBL] [Abstract][Full Text] [Related]
13. Specific MicroRNAs Differentiate Adrenocortical Adenomas from Carcinomas and Correlate With Weiss Histopathologic System.
Feinmesser M; Benbassat C; Meiri E; Benjamin H; Lebanony D; Lebenthal Y; de Vries L; Drozd T; Spector Y
Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):522-31. PubMed ID: 25265426
[TBL] [Abstract][Full Text] [Related]
14. [Adrenocortical tumors with neuroendocrine differentiation].
Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
Giordano TJ
Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein protein and minichromosome maintenance protein-2 expression in adrenocortical tumors.
Saiegh L; Sheikh-Ahmad M; Shechner C; Reut M; Darawsha Y; Zolotov S; Shefer H; Bejar I; Bejar J
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):324-328. PubMed ID: 31703800
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
[TBL] [Abstract][Full Text] [Related]
19. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome.
Adam P; Hahner S; Hartmann M; Heinrich B; Quinkler M; Willenberg HS; Saeger W; Sbiera S; Schmull S; Voelker HU; Ströbel P; Allolio B; Fassnacht M
Mod Pathol; 2010 Dec; 23(12):1596-604. PubMed ID: 20693985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
